Magnolia Medical Company

Magnolia Medical Company was paid $5.32M by Medicaid between Jul 2018 and Dec 2024, across 32 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 18% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Colorado

Rank by total paid#9 of 91

Median peer was paid$53K

This provider vs. median100×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	62,536	$953K
2019	69,760	$1.14M
2020	74,096	$1.02M
2021	37,724	$721K
2022	4,465	$585K
2023	3,153	$416K
2024incomplete	3,565	$485K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	18%	7,789	6,957	$937K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	13%	4,547	3,376	$670K
80361		5.0%	17,852	12,805	$265K
80356		5.0%	17,852	12,805	$265K
80364		5.0%	17,852	12,805	$265K
80365		5.0%	17,851	12,804	$265K
80349		5.0%	17,863	12,805	$265K
80348		5.0%	17,850	12,803	$265K
80346		5.0%	17,843	12,801	$265K
80373		5.0%	17,837	12,799	$265K
80321		4.8%	17,704	12,751	$257K
80353		3.4%	12,109	8,334	$180K

20 more codes

80355		3.3%	11,919	$178K
80354		3.3%	11,822	$176K
80324		2.5%	9,136	$135K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	1.9%	553	$101K
80359		<1%	3,322	$49K
80338		<1%	3,070	$47K
80336		<1%	3,064	$47K
80333		<1%	3,052	$47K
80370		<1%	2,910	$44K
80357		<1%	2,861	$44K
80368		<1%	2,849	$43K
80360		<1%	2,715	$41K
80358		<1%	2,715	$41K
80372		<1%	2,715	$41K
80325		<1%	2,700	$41K
80345		<1%	1,689	$26K
80371		<1%	1,566	$24K
80323		<1%	1,566	$24K
80366		<1%	114	$2K
80375		<1%	12	$207.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRAI, PRADEEP (DIRECTOR)

Parent organizationMAGNOLIA MEDICAL LLC

Same official

Other billing entities under RAI, PRADEEP

Full network →

Provider	Location	Paid
Magnolia Medical Company	Denver, CO	$1.81M
Pro Health One INC	Denver, CO	$1.61M
Forte Health and Wellness INC	Denver, CO	$450K
Forte Health and Wellness INC	Wheat Ridge, CO	$35K
Magnolia Medical Group	Denver, CO	$10K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.